4137 related articles for article (PubMed ID: 6950410)
1. Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.
Vogel CW; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7707-11. PubMed ID: 6950410
[TBL] [Abstract][Full Text] [Related]
2. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
4. Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
Mol Immunol; 1990 Oct; 27(10):957-64. PubMed ID: 2233757
[TBL] [Abstract][Full Text] [Related]
5. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
6. Site-specific activation of the alternative pathway of complement. Synthesis of a hybrid molecule consisting of antibody and cobra venom factor.
Parker CJ; White VF; Falk RJ
Complement; 1986; 3(4):223-35. PubMed ID: 3643079
[TBL] [Abstract][Full Text] [Related]
7. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
8. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
[TBL] [Abstract][Full Text] [Related]
9. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
11. C3 convertase of the human alternative pathway of complement: modulation of enzyme activity and stability by mouse monoclonal antibodies to Bb.
Fishelson Z; Müller-Eberhard HJ
Eur J Immunol; 1987 Feb; 17(2):303-4. PubMed ID: 3644748
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertase.
Tanuma Y; Ohi H; Hatano M
Immunology; 1989 Dec; 68(4):445-8. PubMed ID: 2532618
[TBL] [Abstract][Full Text] [Related]
13. Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation.
Müller B; Müller-Ruchholtz W
Leuk Res; 1987; 11(5):461-8. PubMed ID: 3573809
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
[TBL] [Abstract][Full Text] [Related]
15. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
Bartolotti SR; Peters DK
Clin Exp Immunol; 1979 Sep; 37(3):391-8. PubMed ID: 389495
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
17. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
Phipps D; Menger M; Chadwick JS; Aston WP
Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
19. Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b.
Reiter Y; Fishelson Z
J Immunol; 1989 Apr; 142(8):2771-7. PubMed ID: 2522969
[TBL] [Abstract][Full Text] [Related]
20. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
Fu Q; McPhie P; Gowda DC
Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]